IMA Q2 2022 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$382,000-89.2% YoY

Gross Profit

-$15M-3954.5% margin

Operating Income

-$21M-5484.6% margin

Net Income

-$20M-5364.1% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

-88.7%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$211M

Total Liabilities

$37M

Stockholders' Equity

$174M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$382,000	$4M	-89.2%
Gross Profit	-$15M	-$8M	-93.0%
Operating Income	-$21M	-$13M	-65.1%
Net Income	-$20M	-$13M	-61.6%